Mark_Kuiken / iStockphoto.com
Allergan and the Native American tribe that acquired Allergan’s patents for Restasis (cyclosporine ophthalmic emulsion) have told the US Court of Appeals for the Federal Circuit that patents covering the dry eye treatment are valid.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, sovereign immunity, US Court of Appeals for the Federal Circuit